Stryker buys Israeli brain stent maker for $135M

Editorial Staff | | Cardiovascular Business | Vascular & Endovascular

Stryker has signed a definitive agreement to acquire privately held Surpass Medical in an all-cash transaction for $100 million and up to an additional $35 million in milestone payments.

Founded in 2005 and headquartered in Tel Aviv, Israel, with manufacturing and R&D in Miramar, Fla., Surpass is seeking to develop and commercialize flow diversion stent technology to treat brain aneurysms using a mesh design and delivery system.  

Surpass said its NeuroEndoGraft family uses flow diverters, which are designed to redirect blood flow away from an aneurysm, allowing a stable clot to be formed within the aneurysm pouch. The NeuroEndoGraft has CE Mark with a limited launch underway outside the U.S. In addition, the company will begin enrolling patients in an Investigational Device Exemption clinical trial in the fourth quarter.

The closing of the transaction is subject to customary closing conditions. Upon closing, the transaction is expected to be neutral to Stryker's 2012 earnings per share excluding acquisition and integration-related charges. The transaction is expected to close in the fourth quarter.

Editorial Staff

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."